Apple iPhone Duo Deadline: How To Get Ready Before Pre-Orders Open Oct. 16

If you’re planning to pre-order an iPhone Duo, you can get ready to buy now — but time is running out.

This Robot Finishes Drywall 3X Faster Than Humans. Now It Has $20 Million To Learn More Trades

Construction is hard for robots, but this construction bot finishes drywall 3X faster than humans. And more capability is coming …

Influencer Marketing Investment Jumps 33%. CreatorIQ Ties ROI To Speed.

At CreatorIQ Connect, SharkNinja and Amazon show how faster decisions on creator data lift ROI as influencer marketing spend climbs 33%, per CreatorIQ research

NYT Connections Today: Friday, October 16 Answers Explained

Not sure what today’s NYT Connections answers are all about? Find out just what the different words in today’s grid mean and how they fit together.

These Are The 44 Biggest New-Vehicle Cash Rebates For October

Some car, truck and SUV rebates are in the five-figure range this month, with the best as rich as $25,000.

Disney+ Hit With Multi-National Subscriber Compensation Claim Over Missing 4K And HDR Features

Disney+’s issues with streaming technology patent infringement claims could end up costing it more than just legal fees.

You Can Now Vibe Code A Robot: Standard Bots

If you have an iPad, you can vibe code robots. And potentially save your company millions of dollars while you’re at it.

Rotten Tomatoes’ Critics Deliver ‘Street Fighter’ Reboot A Knockout Punch

“Street Fighter,” a reboot of the live-action movie franchise based on the classic Capcom video game series, is getting splattered with negative reviews from Rotten Tomatoes’ critics.

‘Street Fighter’ Reboot Lands Mixed Reviews From Rotten Tomatoes’ Critics

“Street Fighter,” a reboot of the live-action movie franchise based on the classic Capcom video game series, is getting hit with mixed Rotten Tomatoes reviews that skew on the negative side.

Gene Therapy Cuts Severe Infections 93% In A Rare Immune Disease

Gene therapy cut severe infections 93% in Wiskott-Aldrich syndrome, using patients’ own modified stem cells to treat a rare inherited immune disorder.